Please try another search
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the Funds have declared distributions for April, May and June...
N-able showcases vision for the future that reduces complexities for MSPs and harmonizes modern IT BURLINGTON, Mass.--(BUSINESS WIRE)--(live from Empower, Frisco) “ N-able, Inc. (NYSE: NABL), a...
N-able, Inc. (NYSE: NABL) reported a robust financial performance for the fourth quarter and full year of 2023, with a strong focus on expanding its product offerings and customer base. The company...
Amgen Inc. (NASDAQ:CELG) Revlimid (lenalidomide) and dexamethasone, is already approved in the EU for the treatment of multiple myeloma in patients who have received at least one prior therapy....
Investors in the mining space are always on the lookout for a "perfect 10." Christopher Welch, a mining analyst with Ocean Equities in London, ranks jurisdictions and companies in this interview with...
Bristol-Myers Squibb Company (NYSE:BMY) announced that a phase III ELOQUENT-1 study evaluating Empliciti (elotuzumab) triplet combination in first-line patients with multiple myeloma, who are...
Instrument Type
Region
Sector
Industry
Date
Category
Provider